1. Home
  2. CRBU vs ACU Comparison

CRBU vs ACU Comparison

Compare CRBU & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.68

Market Cap

167.6M

Sector

Health Care

ML Signal

HOLD

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$48.94

Market Cap

160.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
ACU
Founded
2011
1867
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
167.6M
160.6M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
CRBU
ACU
Price
$1.68
$48.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$10.75
$50.00
AVG Volume (30 Days)
1.8M
11.0K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
1.56%
EPS Growth
3.64
1.63
EPS
N/A
0.24
Revenue
N/A
$196,541,816.00
Revenue This Year
$1.63
$5.67
Revenue Next Year
$10.93
$5.25
P/E Ratio
N/A
$198.17
Revenue Growth
N/A
1.05
52 Week Low
$1.22
$35.50
52 Week High
$3.53
$47.56

Technical Indicators

Market Signals
Indicator
CRBU
ACU
Relative Strength Index (RSI) 40.66 74.41
Support Level $1.39 $40.57
Resistance Level $1.73 N/A
Average True Range (ATR) 0.13 1.58
MACD -0.01 0.40
Stochastic Oscillator 28.05 86.58

Price Performance

Historical Comparison
CRBU
ACU

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: